VARKI PAUL has filed 13 insider transactions across 1 company since June 2024.
Most recent transaction: a option exercise of 12563 shares of Avalo Therapeutics, Inc. ($AVTX) on May 06, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | M | Stock Option (Right to Buy) | 12563 | $0.00 | 87,437.0000 | 18,133,968 | 12.56% | 0.07% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | S | Common Stock | 22839 | $21.22 | 13,287.0000 | 18,133,968 | 63.22% | 0.13% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | S | Common Stock | 9253 | $22.70 | 4,034.0000 | 18,133,968 | 69.64% | 0.05% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | S | Common Stock | 400 | $23.71 | 3,634.0000 | 18,133,968 | 9.92% | 0.00% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | M | Stock Option (Right to Buy) | 62500 | $0.00 | 87,500.0000 | 18,133,968 | 41.67% | 0.34% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | M | Common Stock | 62500 | $13.43 | 66,134.0000 | 18,133,968 | 1719.87% | 0.34% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | M | Common Stock | 12563 | $8.04 | 78,697.0000 | 18,133,968 | 19.00% | 0.07% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | S | Common Stock | 37375 | $18.91 | 41,322.0000 | 18,133,968 | 47.49% | 0.21% |
| May 6, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | S | Common Stock | 5196 | $19.78 | 36,126.0000 | 18,133,968 | 12.57% | 0.03% |
| Feb. 26, 2026 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | A | Stock Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 18,133,968 | 9999.99% | 0.44% |
| Dec. 10, 2025 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | F | Common Stock | 1016 | $4.10 | 3,634.0000 | 18,133,968 | 21.85% | 0.01% |
| Jan. 28, 2025 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2024 | Avalo Therapeutics, Inc. | $AVTX | VARKI PAUL | Chief Legal Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |